INmune Bio, Inc. (INMB) Misses Q1 EPS by 8c

INmune Bio, Inc. (NASDAQ: INMB) reported Q1 EPS of ($0.61), $0.08 worse than the analyst estimate of ($0.53). Revenue for the quarter came in at $14 thousand versus the consensus estimate of $43 thousand.

For earnings history and earnings-related data on INmune Bio, Inc. (INMB) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Danone SA (BN:FP) (DANOY) PT Raised to EUR63 at Deutsche Bank
• Isabella Bank added to Russell 2000 index after Nasdaq listing